PathoCare Holdings has announced the receipt of a private third-party tender offer for the secondary purchase of shares from ...
Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US ...
Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its SAPIEN M3 mitral valve ...
Shape Memory Medical’s IMPEDE embolisation plug range has received CE mark as a Class III device under the European Union’s ...
The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for ...
Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter ...
No one can predict what the medical device industry will look like in 2026. Still, the events of 2025 provide meaningful ...
CellBxHealth’s new CEO, Peter Collins, plans to shift the company’s focal point away from the one-stop-shop research model to ...
The US Food and Drug Administration (FDA) is removing a limitation on the use of real-world evidence (RWE), clearing the way for de-identified data to be used for medical device submissions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback